View in EDS HTML Full Text PDF Full Text

Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.

Saved in:
Bibliographic Details
Title: Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.
Authors: Oliveira Roster KI; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Rönn MM; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Gorenburg ER; Program in Human Biology, Stanford University, Stanford, California, USA., Partl DK; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Anderegg N; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Abel Zur Wiesch P; Department of Pharmacy, University of Tromsø - The Arctic University of Norway, Tromsø, Norway., Au C; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Kouyos RD; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Martinez FP; Global Antibiotic Research and Development Partnership, Geneva, Switzerland., Low N; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland., Grad YH; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2026 Jul 18; Vol. 13 (7), pp. ofag447. Date of Electronic Publication: 2026 Jul 18 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42534456
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Oliveira+Roster+KI%22">Oliveira Roster KI</searchLink>; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Rönn+MM%22">Rönn MM</searchLink>; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gorenburg+ER%22">Gorenburg ER</searchLink>; Program in Human Biology, Stanford University, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Partl+DK%22">Partl DK</searchLink>; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Anderegg+N%22">Anderegg N</searchLink>; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Abel+Zur+Wiesch+P%22">Abel Zur Wiesch P</searchLink>; Department of Pharmacy, University of Tromsø - The Arctic University of Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Au+C%22">Au C</searchLink>; Global Antibiotic Research and Development Partnership, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kouyos+RD%22">Kouyos RD</searchLink>; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Martinez+FP%22">Martinez FP</searchLink>; Global Antibiotic Research and Development Partnership, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Low+N%22">Low N</searchLink>; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Grad+YH%22">Grad YH</searchLink>; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101637045%22">Open forum infectious diseases</searchLink> [Open Forum Infect Dis] 2026 Jul 18; Vol. 13 (7), pp. ofag447. <i>Date of Electronic Publication: </i>2026 Jul 18 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Published+by+Oxford+University+Press+on+behalf+of+the+Infectious+Diseases+Society+of+America%22">Published by Oxford University Press on behalf of the Infectious Diseases Society of America </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101637045 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2328-8957 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223288957%22">23288957 </searchLink><i>NLM ISO Abbreviation: </i>Open Forum Infect Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42534456
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/ofid/ofag447
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: ofag447
    Titles:
      – TitleFull: Local Prevalence of Ceftriaxone Resistance Informs Optimal Deployment of New Gonorrhea Treatments.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Oliveira Roster KI
      – PersonEntity:
          Name:
            NameFull: Rönn MM
      – PersonEntity:
          Name:
            NameFull: Gorenburg ER
      – PersonEntity:
          Name:
            NameFull: Partl DK
      – PersonEntity:
          Name:
            NameFull: Anderegg N
      – PersonEntity:
          Name:
            NameFull: Abel Zur Wiesch P
      – PersonEntity:
          Name:
            NameFull: Au C
      – PersonEntity:
          Name:
            NameFull: Kouyos RD
      – PersonEntity:
          Name:
            NameFull: Martinez FP
      – PersonEntity:
          Name:
            NameFull: Low N
      – PersonEntity:
          Name:
            NameFull: Grad YH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 07
              Text: 2026 Jul 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2328-8957
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Open forum infectious diseases
              Type: main
ResultId 1